PortfoliosLab logoPortfoliosLab logo
DRDR.L vs. DOCG.L
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

DRDR.L vs. DOCG.L - Performance Comparison

The chart below illustrates the hypothetical performance of a £10,000 investment in iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) and L&G Healthcare Breakthrough UCITS ETF (DOCG.L). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

DRDR.L vs. DOCG.L - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
DRDR.L
iShares Healthcare Innovation UCITS ETF USD (Acc)
-3.14%10.25%2.62%-2.51%-14.93%-5.21%48.69%0.75%
DOCG.L
L&G Healthcare Breakthrough UCITS ETF
-8.11%16.50%3.57%-6.64%-25.94%1.46%63.33%0.69%

Returns By Period

In the year-to-date period, DRDR.L achieves a -3.14% return, which is significantly higher than DOCG.L's -8.11% return.


DRDR.L

1D
1.51%
1M
-5.29%
YTD
-3.14%
6M
7.57%
1Y
14.45%
3Y*
3.07%
5Y*
-2.01%
10Y*

DOCG.L

1D
0.82%
1M
-8.16%
YTD
-8.11%
6M
8.74%
1Y
17.96%
3Y*
0.93%
5Y*
-4.99%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


DRDR.L vs. DOCG.L - Expense Ratio Comparison

DRDR.L has a 0.40% expense ratio, which is lower than DOCG.L's 0.49% expense ratio.


Return for Risk

DRDR.L vs. DOCG.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DRDR.L
DRDR.L Risk / Return Rank: 4545
Overall Rank
DRDR.L Sharpe Ratio Rank: 4747
Sharpe Ratio Rank
DRDR.L Sortino Ratio Rank: 4646
Sortino Ratio Rank
DRDR.L Omega Ratio Rank: 4040
Omega Ratio Rank
DRDR.L Calmar Ratio Rank: 5050
Calmar Ratio Rank
DRDR.L Martin Ratio Rank: 4040
Martin Ratio Rank

DOCG.L
DOCG.L Risk / Return Rank: 4242
Overall Rank
DOCG.L Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
DOCG.L Sortino Ratio Rank: 4747
Sortino Ratio Rank
DOCG.L Omega Ratio Rank: 3939
Omega Ratio Rank
DOCG.L Calmar Ratio Rank: 4242
Calmar Ratio Rank
DOCG.L Martin Ratio Rank: 3636
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DRDR.L vs. DOCG.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) and L&G Healthcare Breakthrough UCITS ETF (DOCG.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DRDR.LDOCG.LDifference

Sharpe ratio

Return per unit of total volatility

0.84

0.84

0.00

Sortino ratio

Return per unit of downside risk

1.24

1.29

-0.06

Omega ratio

Gain probability vs. loss probability

1.16

1.16

0.00

Calmar ratio

Return relative to maximum drawdown

1.27

1.09

+0.19

Martin ratio

Return relative to average drawdown

3.69

3.29

+0.40

DRDR.L vs. DOCG.L - Sharpe Ratio Comparison

The current DRDR.L Sharpe Ratio is 0.84, which is comparable to the DOCG.L Sharpe Ratio of 0.84. The chart below compares the historical Sharpe Ratios of DRDR.L and DOCG.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


DRDR.LDOCG.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.84

0.84

0.00

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.11

-0.23

+0.11

Sharpe Ratio (All Time)

Calculated using the full available price history

0.33

0.17

+0.16

Correlation

The correlation between DRDR.L and DOCG.L is 0.87, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


Dividends

DRDR.L vs. DOCG.L - Dividend Comparison

Neither DRDR.L nor DOCG.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

DRDR.L vs. DOCG.L - Drawdown Comparison

The maximum DRDR.L drawdown since its inception was -38.49%, smaller than the maximum DOCG.L drawdown of -51.45%. Use the drawdown chart below to compare losses from any high point for DRDR.L and DOCG.L.


Loading graphics...

Drawdown Indicators


DRDR.LDOCG.LDifference

Max Drawdown

Largest peak-to-trough decline

-38.49%

-51.45%

+12.96%

Max Drawdown (1Y)

Largest decline over 1 year

-11.00%

-15.66%

+4.66%

Max Drawdown (5Y)

Largest decline over 5 years

-35.81%

-49.65%

+13.84%

Current Drawdown

Current decline from peak

-20.29%

-33.67%

+13.38%

Average Drawdown

Average peak-to-trough decline

-15.08%

-26.99%

+11.91%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.79%

5.17%

-1.38%

Volatility

DRDR.L vs. DOCG.L - Volatility Comparison

The current volatility for iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) is 5.39%, while L&G Healthcare Breakthrough UCITS ETF (DOCG.L) has a volatility of 6.30%. This indicates that DRDR.L experiences smaller price fluctuations and is considered to be less risky than DOCG.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


DRDR.LDOCG.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.39%

6.30%

-0.91%

Volatility (6M)

Calculated over the trailing 6-month period

10.80%

14.05%

-3.25%

Volatility (1Y)

Calculated over the trailing 1-year period

17.09%

21.34%

-4.25%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

17.62%

21.92%

-4.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.59%

23.40%

-4.81%